“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

A Japanese hospital said Monday it has completed a clinical test to transplant induced pluripotent stem cells that produce insulin to treat a patient with type 1 diabetes, in a step that could ease ...

KYOTO—Kyoto University Hospital officials announced on April 14 that a research team conducted a clinical trial in February to transplant lab-grown pancreatic islets into a woman in her 40s who has ...

Q: My fiance and I plan to have kids someday. I was wondering if it would be beneficial to keep our babies’ umbilical cords, ...

Kyoto University Hospital says it has started clinical trials to transplant cells created from induced pluripotent stem cells into type one diabetes patients.

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza.

For type 1 diabetes, immunotherapy approaches show promise for delaying beta cell destruction when administered early in diagnosis. Researchers are also exploring beta cell transplantation ...

A new study reveals how the Dnmt3a mutation drives blood stem cell overgrowth, contributing to clonal hematopoiesis and ...

Stem cells are defined by their naive status and ability to become a new, specialized type of cell under the right conditions ...